Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
1.760
-0.020 (-1.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,218,051
Open
1.790
Bid (Size)
1.770 (2)
Ask (Size)
1.840 (23)
Prev. Close
1.780
Today's Range
1.700 - 1.840
52wk Range
1.700 - 30.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
April 10, 2024
Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, visual decline, and overall disease burden. Safety profile consistent.
Via
Benzinga
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
April 10, 2024
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Performance
YTD
-88.24%
-88.24%
1 Month
-38.89%
-38.89%
3 Month
-88.56%
-88.56%
6 Month
-88.82%
-88.82%
1 Year
-93.76%
-93.76%
More News
Read More
AMLX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 08, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Unveiling 6 Analyst Insights On Amylyx Pharma
April 08, 2024
Via
Benzinga
AMLX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 08, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX)
April 08, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
AMLX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX
April 08, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
April 08, 2024
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
AMLX IMPORTANT DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 07, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
AMLX IMPORTANT DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 07, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMLX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 06, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
AMLX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 06, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMLX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 05, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
AMLX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 05, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMYLYX PHARMACEUTICALS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX
April 05, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Kaplan Fox & Kilsheimer LLP Reminds Amylyx (NASDAQ: AMLX) Investors of a Class Action Lawsuit and April 9, 2024 Lead Plaintiff Deadline
April 04, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Kaplan Fox & Kilsheimer LLP Reminds Amylyx (NASDAQ: AMLX) Investors of a Class Action Lawsuit and April 9, 2024 Lead Plaintiff Deadline
April 04, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy
April 04, 2024
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
AMLX FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 03, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMLX FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 03, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx
April 03, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
AMLX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 02, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
AMLX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 02, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMLX FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 01, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
AMLX FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
April 01, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.